 |
Regulations of Connecticut State Agencies (Last Updated: June 14,2023) |
 |
Title18 Correctional Institutions and Department of Correction |
|
|
SubTitle18-81q. Return of Drug Products From Correctional Institutions |
| Sec. 18-81q-1. Return of drug products from correctional institutions |
|
Latest version.
|
|
(a) Any pharmacy that accepts for return drug products dispensed to correctional institutions, pursuant to section 27 of Public Act No. 01-9, June Special Session, shall comply with the requirements of this section. (b) A pharmacy shall not accept for return any drug products that do not meet the criteria for return under section 27 of Public Act No. 01-9, June Special Session. (c) A pharmacy shall physically inspect all drug products that are returned by correctional institutions. Any drug products in original manufacturer’s dispensing packages that have been opened, have had doses removed, or show any signs of tampering shall not be returned to stock. Any drug products packaged in unit dose or blister type packaging that appear to have been removed from and returned to the dispensing package, or drug products in such packaging that appears to have been tampered with or the integrity of which appears to be compromised in any way, shall not be returned to stock, except as permitted in subsection (d)(2) of this section. (d) Except as provided in subsections (b) and (c) of this section, a pharmacy may return to stock for re-dispensing drug products: (1) packaged in original manufacturer’s dispensing packages; (2) packaged in unit dose or blister type packaging whose individual labeling and integrity remains intact even though doses may have been removed from the outer package; or (3) originally packaged by the pharmacy into multiple dose blister packaging. Except as otherwise permitted by this subdivision, such drug products shall be removed from the original dispensing package before being placed into pharmacy stock for re-dispensing. This process shall be done in a manner that insures that the lot number and expiration date for the drug product are maintained and that the individual doses of the drug product are not exposed to possible adulteration or cross-contamination. Generically equivalent drug products from more than one drug manufacturer shall not be co-mingled. Removal of the drug product from the original dispensing package prior to re-dispensing shall not be required for packaging from which no doses have been removed and for packaging that allows disassembly without handling the drug product, while maintaining product identification, lot number, and expiration date. (e) (1) All drug products re-dispensed on prescription from the pharmacy shall be labeled with all required information, including lot number and expiration date. (2) The expiration date assigned to the drug product for re-dispensing shall be no later than the expiration date assigned to the product when originally dispensed, or no later than the earliest expiration date originally assigned to any dose contained in the repackaged multiple dose blister card dispensed. (3) The lot number assigned shall be the manufacturer’s original lot number for products dispensed in manufacturers’ original packaging, or a lot number assigned by the pharmacy for a repackaged product, from which the original lot numbers of the doses contained may be referenced. |
|
(Adopted effective September 10, 2002) |